AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Lifeward Ltd. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing for Lifeward Ltd. (LFWD) discloses the first reportable transaction by director Hadar Levy on 1 Aug 2025.

  • Transaction: Acquisition of 35,920 ordinary shares via restricted stock units (RSUs) granted under the 2025 Incentive Compensation Plan. The award was booked at $0.00 cost, indicating a compensation grant rather than a market purchase.
  • Vesting terms: RSUs vest in four equal quarterly tranches beginning three months after the grant date.
  • Post-transaction ownership: Levy now holds 51,576 shares indirectly through the company ESOP.
  • The reported share balances already reflect Lifeward’s 1-for-7 reverse share split effective 15 Mar 2024.

No derivative securities or sales were reported. The filing shows additional equity alignment for a board member but does not involve cash outlay or immediate market activity, so short-term dilution and trading-signal effects are minimal.

Deposito del Modulo 4 per Lifeward Ltd. (LFWD) rivela la prima transazione segnalabile da parte del direttore Hadar Levy in data 1 agosto 2025.

  • Transazione: Acquisizione di 35.920 azioni ordinarie tramite unità azionarie vincolate (RSU) concesse nell'ambito del Piano di Incentivi 2025. Il premio è stato registrato a costo $0,00, indicando un riconoscimento compensativo e non un acquisto di mercato.
  • Termini di maturazione: Le RSU maturano in quattro tranche trimestrali uguali a partire da tre mesi dopo la data di concessione.
  • Proprietà post-transazione: Levy detiene ora indirettamente 51.576 azioni tramite il piano ESOP aziendale.
  • I saldi azionari riportati riflettono già la scissione inversa 1-per-7 di Lifeward, efficace dal 15 marzo 2024.

Non sono stati segnalati titoli derivati o vendite. Il deposito mostra un ulteriore allineamento azionario per un membro del consiglio, senza coinvolgere esborsi di denaro o attività di mercato immediate, pertanto gli effetti di diluizione a breve termine e i segnali di trading sono minimi.

Presentación del Formulario 4 para Lifeward Ltd. (LFWD) revela la primera transacción reportable por el director Hadar Levy el 1 de agosto de 2025.

  • °Õ°ù²¹²Ô²õ²¹³¦³¦¾±Ã³²Ô: Adquisición de 35,920 acciones ordinarias mediante unidades restringidas de acciones (RSUs) otorgadas bajo el Plan de Compensación Incentivada 2025. La concesión se registró a un costo de $0.00, indicando una asignación compensatoria en lugar de una compra en el mercado.
  • Términos de adquisición: Las RSUs se consolidan en cuatro tramos trimestrales iguales comenzando tres meses después de la fecha de otorgamiento.
  • Propiedad posterior a la transacción: Levy ahora posee indirectamente 51,576 acciones a través del ESOP de la compañía.
  • Los saldos de acciones reportados ya reflejan la consolidación inversa 1 por 7 de Lifeward, efectiva desde el 15 de marzo de 2024.

No se reportaron valores derivados ni ventas. La presentación muestra un mayor alineamiento patrimonial para un miembro del consejo, pero no implica desembolso de efectivo ni actividad inmediata en el mercado, por lo que los efectos de dilución a corto plazo y señales de negociación son mínimos.

Lifeward Ltd.(LFWD)ì� Form 4 ì œì¶œì€ ì´ì‚¬ Hadar Levyì� ì²� ë³´ê³  가능한 거래ë¥� 2025ë…� 8ì›� 1ì�ì—� 공개합니ë‹�.

  • 거래 ë‚´ìš©: 2025ë…� ì¸ì„¼í‹°ë¸Œ ë³´ìƒ ê³„íšì—� ë”°ë¼ ë¶€ì—¬ëœ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSUs)ë¥� 통해 35,920 보통ì£�ë¥� ì·¨ë“했습니다. ì� ë³´ìƒì€ $0.00 비용으로 기ë¡ë˜ì–´ 시장 구매가 아닌 ë³´ìƒ ë¶€ì—¬ìž„ì� 나타냅니ë‹�.
  • 베스íŒ� ì¡°ê±´: RSUëŠ� 부여ì¼ë¡œë¶€í„� 3개월 후부í„� 시작하여 4ê°œì˜ ë™ì¼í•� 분기ë³� ë¶„í• ë¡� 베스팅ë©ë‹ˆë‹¤.
  • 거래 í›� 소유ê¶�: LevyëŠ� 현재 회사 ESOPë¥� 통해 ê°„ì ‘ì ìœ¼ë¡� 51,576ì£�ë¥� 보유하고 있습니다.
  • ë³´ê³ ë� ì£¼ì‹ ìž”ì•¡ì€ 2024ë…� 3ì›� 15ì¼ë¶€í„� 효력ì� ë°œìƒí•� Lifewardì� 1대 7 액면병합ì� ì´ë¯¸ ë°˜ì˜í•˜ê³  있습니다.

íŒŒìƒ ì¦ê¶Œì´ë‚˜ 매ë„ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�. ì´ë²ˆ ì œì¶œì€ ì´ì‚¬íš� 구성ì›ì˜ 추가 ì§€ë¶� ì •ë ¬ì� 보여주지ë§� 현금 지출ì´ë‚� 즉ê°ì ì¸ 시장 활ë™ì� í¬í•¨ë˜ì§€ 않아 단기 í¬ì„ ë°� 거래 신호 ì˜í–¥ì€ 미미합니ë‹�.

Dépôt du formulaire 4 pour Lifeward Ltd. (LFWD) révèle la première transaction déclarable par le directeur Hadar Levy le 1er août 2025.

  • Transaction : Acquisition de 35 920 actions ordinaires via des unités d'actions restreintes (RSU) attribuées dans le cadre du Plan de Compensation Incitative 2025. L'attribution a été enregistrée à un coût de 0,00 $, indiquant une attribution de rémunération plutôt qu'un achat sur le marché.
  • Modalités d'acquisition : Les RSU acquièrent leurs droits en quatre tranches trimestrielles égales à partir de trois mois après la date d'attribution.
  • Propriété après la transaction : Levy détient désormais indirectement 51 576 actions via le plan ESOP de la société.
  • Les soldes d'actions déclarés reflètent déjà la regroupement d'actions inversé 1 pour 7 de Lifeward, effectif depuis le 15 mars 2024.

Aucun titre dérivé ni vente n'a été signalé. Le dépôt montre un alignement supplémentaire des capitaux propres pour un membre du conseil d'administration mais n'implique pas de sortie de trésorerie ni d'activité immédiate sur le marché, de sorte que les effets de dilution à court terme et les signaux de négociation sont minimes.

Formular 4-Einreichung für Lifeward Ltd. (LFWD) offenbart die erste meldepflichtige Transaktion des Direktors Hadar Levy am 1. August 2025.

  • Transaktion: Erwerb von 35.920 Stammaktien durch Restricted Stock Units (RSUs), die im Rahmen des Incentive Compensation Plan 2025 gewährt wurden. Die Zuteilung wurde mit $0,00 Kosten verbucht, was auf eine Vergütungszuteilung und keinen Marktankauf hinweist.
  • Vesting-Bedingungen: RSUs werden in vier gleichen vierteljährlichen Tranchen beginnend drei Monate nach dem Gewährungsdatum fällig.
  • Eigentumsverhältnisse nach der Transaktion: Levy hält nun indirekt 51.576 Aktien über den ESOP des Unternehmens.
  • Die gemeldeten Aktienbestände berücksichtigen bereits den 1-zu-7 Reverse-Split von Lifeward, der am 15. März 2024 wirksam wurde.

Es wurden keine Derivate oder Verkäufe gemeldet. Die Einreichung zeigt eine zusätzliche Eigenkapitalbindung für ein Vorstandsmitglied, beinhaltet jedoch keine Barauslagen oder unmittelbare Marktaktivitäten, sodass kurzfristige Verwässerungs- und Handelssignaleffekte minimal sind.

Positive
  • 35,920 RSUs granted boosts director ownership to 51,576 shares, enhancing insider alignment with shareholders
  • Vesting over four quarters encourages sustained engagement by the board member
Negative
  • None.

Insights

TL;DR: Director received 35,920 RSUs; ownership rises to 51,576 shares; no cash paid—moderately positive alignment signal, limited market impact.

The grant increases insider exposure without triggering open-market demand or cash deployment, so liquidity impact is negligible. While insider acquisitions can be bullish, compensation-based awards carry less signaling power than voluntary purchases. The quarterly vesting schedule spreads potential dilution over a year and keeps Levy incentivised through 2026. Given Lifeward’s recent 1-for-7 reverse split, the absolute share count remains modest. Overall, the filing modestly improves governance alignment but is unlikely to move LFWD’s valuation near-term.

TL;DR: Grant supports pay-for-performance structure; routine equity compensation—neutral corporate-governance event.

Equity grants to directors are standard practice for emerging health-tech firms like Lifeward. Quarterly vesting promotes ongoing engagement, and disclosure complies with Section 16. No red flags such as accelerated vesting, option repricing, or insider sales appear. Because the shares originate from an approved plan, shareholder dilution was previously authorized. The event is administratively sound but not materially transformative.

Deposito del Modulo 4 per Lifeward Ltd. (LFWD) rivela la prima transazione segnalabile da parte del direttore Hadar Levy in data 1 agosto 2025.

  • Transazione: Acquisizione di 35.920 azioni ordinarie tramite unità azionarie vincolate (RSU) concesse nell'ambito del Piano di Incentivi 2025. Il premio è stato registrato a costo $0,00, indicando un riconoscimento compensativo e non un acquisto di mercato.
  • Termini di maturazione: Le RSU maturano in quattro tranche trimestrali uguali a partire da tre mesi dopo la data di concessione.
  • Proprietà post-transazione: Levy detiene ora indirettamente 51.576 azioni tramite il piano ESOP aziendale.
  • I saldi azionari riportati riflettono già la scissione inversa 1-per-7 di Lifeward, efficace dal 15 marzo 2024.

Non sono stati segnalati titoli derivati o vendite. Il deposito mostra un ulteriore allineamento azionario per un membro del consiglio, senza coinvolgere esborsi di denaro o attività di mercato immediate, pertanto gli effetti di diluizione a breve termine e i segnali di trading sono minimi.

Presentación del Formulario 4 para Lifeward Ltd. (LFWD) revela la primera transacción reportable por el director Hadar Levy el 1 de agosto de 2025.

  • °Õ°ù²¹²Ô²õ²¹³¦³¦¾±Ã³²Ô: Adquisición de 35,920 acciones ordinarias mediante unidades restringidas de acciones (RSUs) otorgadas bajo el Plan de Compensación Incentivada 2025. La concesión se registró a un costo de $0.00, indicando una asignación compensatoria en lugar de una compra en el mercado.
  • Términos de adquisición: Las RSUs se consolidan en cuatro tramos trimestrales iguales comenzando tres meses después de la fecha de otorgamiento.
  • Propiedad posterior a la transacción: Levy ahora posee indirectamente 51,576 acciones a través del ESOP de la compañía.
  • Los saldos de acciones reportados ya reflejan la consolidación inversa 1 por 7 de Lifeward, efectiva desde el 15 de marzo de 2024.

No se reportaron valores derivados ni ventas. La presentación muestra un mayor alineamiento patrimonial para un miembro del consejo, pero no implica desembolso de efectivo ni actividad inmediata en el mercado, por lo que los efectos de dilución a corto plazo y señales de negociación son mínimos.

Lifeward Ltd.(LFWD)ì� Form 4 ì œì¶œì€ ì´ì‚¬ Hadar Levyì� ì²� ë³´ê³  가능한 거래ë¥� 2025ë…� 8ì›� 1ì�ì—� 공개합니ë‹�.

  • 거래 ë‚´ìš©: 2025ë…� ì¸ì„¼í‹°ë¸Œ ë³´ìƒ ê³„íšì—� ë”°ë¼ ë¶€ì—¬ëœ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSUs)ë¥� 통해 35,920 보통ì£�ë¥� ì·¨ë“했습니다. ì� ë³´ìƒì€ $0.00 비용으로 기ë¡ë˜ì–´ 시장 구매가 아닌 ë³´ìƒ ë¶€ì—¬ìž„ì� 나타냅니ë‹�.
  • 베스íŒ� ì¡°ê±´: RSUëŠ� 부여ì¼ë¡œë¶€í„� 3개월 후부í„� 시작하여 4ê°œì˜ ë™ì¼í•� 분기ë³� ë¶„í• ë¡� 베스팅ë©ë‹ˆë‹¤.
  • 거래 í›� 소유ê¶�: LevyëŠ� 현재 회사 ESOPë¥� 통해 ê°„ì ‘ì ìœ¼ë¡� 51,576ì£�ë¥� 보유하고 있습니다.
  • ë³´ê³ ë� ì£¼ì‹ ìž”ì•¡ì€ 2024ë…� 3ì›� 15ì¼ë¶€í„� 효력ì� ë°œìƒí•� Lifewardì� 1대 7 액면병합ì� ì´ë¯¸ ë°˜ì˜í•˜ê³  있습니다.

íŒŒìƒ ì¦ê¶Œì´ë‚˜ 매ë„ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�. ì´ë²ˆ ì œì¶œì€ ì´ì‚¬íš� 구성ì›ì˜ 추가 ì§€ë¶� ì •ë ¬ì� 보여주지ë§� 현금 지출ì´ë‚� 즉ê°ì ì¸ 시장 활ë™ì� í¬í•¨ë˜ì§€ 않아 단기 í¬ì„ ë°� 거래 신호 ì˜í–¥ì€ 미미합니ë‹�.

Dépôt du formulaire 4 pour Lifeward Ltd. (LFWD) révèle la première transaction déclarable par le directeur Hadar Levy le 1er août 2025.

  • Transaction : Acquisition de 35 920 actions ordinaires via des unités d'actions restreintes (RSU) attribuées dans le cadre du Plan de Compensation Incitative 2025. L'attribution a été enregistrée à un coût de 0,00 $, indiquant une attribution de rémunération plutôt qu'un achat sur le marché.
  • Modalités d'acquisition : Les RSU acquièrent leurs droits en quatre tranches trimestrielles égales à partir de trois mois après la date d'attribution.
  • Propriété après la transaction : Levy détient désormais indirectement 51 576 actions via le plan ESOP de la société.
  • Les soldes d'actions déclarés reflètent déjà la regroupement d'actions inversé 1 pour 7 de Lifeward, effectif depuis le 15 mars 2024.

Aucun titre dérivé ni vente n'a été signalé. Le dépôt montre un alignement supplémentaire des capitaux propres pour un membre du conseil d'administration mais n'implique pas de sortie de trésorerie ni d'activité immédiate sur le marché, de sorte que les effets de dilution à court terme et les signaux de négociation sont minimes.

Formular 4-Einreichung für Lifeward Ltd. (LFWD) offenbart die erste meldepflichtige Transaktion des Direktors Hadar Levy am 1. August 2025.

  • Transaktion: Erwerb von 35.920 Stammaktien durch Restricted Stock Units (RSUs), die im Rahmen des Incentive Compensation Plan 2025 gewährt wurden. Die Zuteilung wurde mit $0,00 Kosten verbucht, was auf eine Vergütungszuteilung und keinen Marktankauf hinweist.
  • Vesting-Bedingungen: RSUs werden in vier gleichen vierteljährlichen Tranchen beginnend drei Monate nach dem Gewährungsdatum fällig.
  • Eigentumsverhältnisse nach der Transaktion: Levy hält nun indirekt 51.576 Aktien über den ESOP des Unternehmens.
  • Die gemeldeten Aktienbestände berücksichtigen bereits den 1-zu-7 Reverse-Split von Lifeward, der am 15. März 2024 wirksam wurde.

Es wurden keine Derivate oder Verkäufe gemeldet. Die Einreichung zeigt eine zusätzliche Eigenkapitalbindung für ein Vorstandsmitglied, beinhaltet jedoch keine Barauslagen oder unmittelbare Marktaktivitäten, sodass kurzfristige Verwässerungs- und Handelssignaleffekte minimal sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levy Hadar

(Last) (First) (Middle)
C/O LIFEWARD LTD.
200 DONALD LYNCH BLVD.

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, par value NIS 1.75 per share 08/01/2025 A 35,920(1) A $0.00 51,576(2) I ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
2. The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.
/s/ Almog Adar, as Attorney-in-Fact 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Lifeward (LFWD) shares did Hadar Levy acquire?

Levy received 35,920 ordinary shares in the form of RSUs.

Was the insider transaction a purchase or a grant?

It was a compensation grant; no cash was paid (reported price $0.00).

What is Levy's total beneficial ownership after the transaction?

He now beneficially owns 51,576 shares, held indirectly through the ESOP.

When do the RSUs granted to Levy vest?

They vest in four equal quarterly tranches starting three months after 1 Aug 2025.

Did the filing report any sales of LFWD shares?

No sales were disclosed; only an acquisition of RSUs was reported.

How did Lifeward's 1-for-7 reverse split affect the share numbers?

The reported figures already reflect the post-split share count effective 15 Mar 2024.
Lifeward Ltd

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Latest SEC Filings

LFWD Stock Data

11.00M
15.31M
2.49%
3.11%
10.3%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Israel
MARLBOROUGH